Analyses of data from the Clinical Proteomic Tumor Analysis Consortium using the UALCAN tool revealed that the expression of PELP1 is higher in HCC tumors compared with normal liver tissues (Fig. 1C). Here, PELP1 is linked to hepatocellular carcinoma.